首页 | 本学科首页   官方微博 | 高级检索  
检索        

LC-MS/MS法测定犬体内托拉塞米浓度及相对生物利用度研究
引用本文:李瑞兴,樊慧蓉,魏广力,任晓文,司端运,刘昌孝.LC-MS/MS法测定犬体内托拉塞米浓度及相对生物利用度研究[J].中国临床药理学与治疗学,2012,17(2):199-205.
作者姓名:李瑞兴  樊慧蓉  魏广力  任晓文  司端运  刘昌孝
作者单位:1. 天津中医药大学,天津300193;天津药物研究院,释药技术与药代动力学国家重点实验室,天津300193
2. 天津药物研究院,释药技术与药代动力学国家重点实验室,天津300193
基金项目:国家973项目(2010CB735602)
摘    要:目的:建立LC-MS/MS法测定Beagle犬体内托拉塞米的浓度,并研究托拉塞米缓释片的相对生物利用度。方法:色谱柱为Waters Sym-metry-C18(100mm×4.6mm,5μm);流动相为甲醇∶20mmol/L甲酸铵(65∶35,V∶V);流速0.4mL/min;柱温30℃。采用两制剂双周期随机交叉试验设计,分别给予6只Beagle犬受试制剂或参比制剂5mg,采用LC-MS/MS法测定给药后不同时间的血药浓度。结果:托拉塞米线性范围为0.02~5μg/mL,最低定量限为0.02μg/mL,分析方法灵敏、稳定、特异性高。受试制剂和参比制剂的主要药动学参数:峰浓度(Cmax)、达峰时间(tmax)和药-时曲线下面积(AUC0-48h)分别为(2.6±0.5)g/mL和(3.0±0.6)g/mL、(3.3±1.4)h和(1.2±0.8)h、(36.1±11.0)g.h.mL-1和(32.1±13.1)g.h.mL-1。以AUC0-48h计算,受试制剂的相对生物利用度F为(118.0±28.3)%。结论:该方法操作简单、准确、重复性好,并成功地运用于犬体内托拉塞米相对生物利用度的研究。

关 键 词:托拉塞米  LC-MS/MS  相对生物利用度

LC-MS/MS determination of torasemide in Beagle dog plasma and bioavailability evaluation
LI Rui-xing , FAN Hui-rong , WEI Guang-li , REN Xiao-wen , SI Duan-yun , LIU Chang-xiao.LC-MS/MS determination of torasemide in Beagle dog plasma and bioavailability evaluation[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2012,17(2):199-205.
Authors:LI Rui-xing  FAN Hui-rong  WEI Guang-li  REN Xiao-wen  SI Duan-yun  LIU Chang-xiao
Institution:1 Tianjin University of Traditional Chinese Medicine,Tianjin 300193,Tianjin,China;2 State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research,Tianjin 300193,Tianjin,China
Abstract:AIM: To establish an LC-MS/MS method for the determination of torasemide in Beagle dog plasma,and study the relative bioavailability of the torasemide sustained release tablets.METHODS: A reversed phase HPLC column of Waters Symmetry-C18(100 mm×4.6 mm,5 μm) was used in the experiment.Acetonitrile-20 mmol/L ammonium formate(65∶35,V/V) was used as mobile phase at the flow rate of 0.4 mL/min,the column temperature was set at 30 ℃.A single oral dose of 5 mg torasemide release tablets or reference tablets were given to 6 Beagle dogs in an open randomized two way crossover design.The concentrations of plasma samples collected at the different time were determined by LC-MS/MS method.RESULTS:With the linear range of 0.02-5 μg/mL and the lower limit quantification of 0.02 μg/mL,the LC-MS/MS method had high sensitivity,stability and specificity.The main pharmacokinetic parameters of test sustained release tablets and reference tablets were as follows:the Cmax were(2.6±0.5) μg/mL and(3.0±0.6) g/mL,the tmax were(3.3±1.4) h and(1.2±0.8) h,the AUC0-48 h were(36.1±11.0) μg·h·mL-1 and(32.1±13.1) μg·h·mL-1.Compared to regular tablets,the bioavailability of sustained release tablets was(118.0±28.3)%.CONCLUSION: The method is simple,accurate and robust for the determination of torasemide in Beagle dog plasma,and successfully applied it to the bioavailability evaluation of torasemide sustained release tablets given to Beagle dogs.
Keywords:Torasemide  LC-MS/ MS  Relative bioavailability
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号